The Effect of Video-Assisted Mindfulness-Based Breathing on Quality of Life and Mental Well-Being in Individuals With Breast Cancer
1 other identifier
interventional
50
0 countries
N/A
Brief Summary
This study aims to evaluate the effect of video-assisted mindfulness-based breathing on quality of life and mental well-being in individuals with breast cancer. Breast cancer patients often experience physical and psychological challenges that negatively affect their quality of life. Mindfulness-based breathing is a simple, non-invasive method that may help reduce stress and improve well-being. In this randomized controlled study, participants will be assigned to either an intervention group or a control group. The intervention group will receive a face-to-face breathing training session and will practice daily mindfulness-based breathing exercises using a 5-minute video for 6 weeks. The control group will receive routine care. Outcomes will be measured at baseline and after 6 weeks using validated scales assessing quality of life and mental well-being. This study aims to provide evidence for a simple and accessible supportive care method for individuals with breast cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable breast-cancer
Started Sep 2026
Shorter than P25 for not_applicable breast-cancer
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 2, 2026
CompletedFirst Posted
Study publicly available on registry
May 8, 2026
CompletedStudy Start
First participant enrolled
September 2, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
March 2, 2027
Study Completion
Last participant's last visit for all outcomes
June 2, 2027
May 8, 2026
May 1, 2026
6 months
May 2, 2026
May 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Quality of Life
Quality of life will be assessed using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) and the breast cancer-specific module (EORTC QLQ-BR23). Scores range from 0 to 100. Higher scores on global health status and functional scales indicate better quality of life, while higher scores on symptom scales indicate greater symptom burden.
Baseline and 6 weeks after randomization
Change in Mental Well-Being
Mental well-being will be assessed using the Warwick-Edinburgh Mental Well-Being Scale (WEMWBS). The scale includes 14 positively worded items scored on a 5-point Likert scale. Total scores range from 14 to 70, with higher scores indicating higher mental well-being.
Baseline and 6 weeks after randomization
Study Arms (2)
Experimental Group
EXPERIMENTALParticipants will receive video-assisted mindfulness-based breathing training, including a face-to-face session followed by daily 5-minute guided breathing exercises for 6 weeks.
Control Group
NO INTERVENTIONParticipants will receive routine clinical care without any additional intervention during the study period.
Interventions
A structured mindfulness-based breathing program consisting of an initial face-to-face training session followed by a 6-week daily video-guided breathing practice delivered through an online platform.
Eligibility Criteria
You may qualify if:
- Diagnosed with breast cancer Aged 18 years or older Stage I, II, or III breast cancer Completed at least 4 cycles of chemotherapy Completed chemotherapy treatment Able to understand and speak Turkish Has access to a digital device (smartphone, tablet, or computer) Willing to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ege Universitylead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The outcome assessor will be blinded to group allocation. Participants and intervention providers will not be blinded due to the nature of the intervention.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant
Study Record Dates
First Submitted
May 2, 2026
First Posted
May 8, 2026
Study Start (Estimated)
September 2, 2026
Primary Completion (Estimated)
March 2, 2027
Study Completion (Estimated)
June 2, 2027
Last Updated
May 8, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share